Covaxin effective in neutralising double-mutant strain, says ICMR
India’s indigenous vaccine is developed by Bharat Biotech
Covaxin had received Emergency Use Authorisation in India and abroad
ICMR-National Institute of Virology demonstrated Covaxin’s potential against UK and Brazil variants
Successfully isolated and cultured multiple variants of the coronavirus
Bharat Biotech will produce 30 million doses of its Covaxin next month
The vaccine maker ramped up production capacity to 700 million doses per annum
